SHOREVIEW, Minn., March 17, 2017 /PRNewswire/ --áTSI Incorporated, the world leader in particle counting instruments,
The mobile adaptive bioproduction suite represents a new approach to the design of controlled aseptic environments to adapt emerging biopharmaceutical production processes and facilities to meet evolving production and validation requirements within the industry. TSI participates as a recognized, valuable partner with its BioTrak Real-Time Viable Particle Counter as the most efficient environmental monitoring instrument available for aseptic manufacturing facilities.
The BioTrak Real-Time Viable Particle Counter provides reliable in-process environmental monitoring without human intervention. Three instruments in one, the BioTrak Particle Counter offers continuous ISO-compliant optical particle counting, real-time viable particle counting and microbial sample collection for speciation---designed to reduce costs and improve quality.
"We're honored that Germfree has extended to us this exciting opportunity to be a part of this innovative display," said Patrick Hutchins, TSI Global Product Manager. "It is the perfect venue for attendees to familiarize themselves with the most efficient, cost-saving solutions available on the market today, and for TSI to showcase our innovative technology."
"TSI's BioTrak Real-Time Viable Particle Counter is a next-generation technology that combines the power of efficient and effective viable particulate detection with the ultimate trending tools for improved process performance monitoring and trending," said Carol Houts, Director of Quality Germfree. "We are excited to have TSI as an exhibit partner to demonstrate advanced technological approaches to solving the biopharmaceutical industry's challenge to meet risk management and process improvement goals and objectives."
CLICK HERE to request more information about the BioTrak Real-Time Viable Particle Counter or stop by our booth 1939 at INTERPHEX.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tsi-participates-in-germfrees-mobile-adaptive-bioproduction-suite-at-interphex-300425689.html
SOURCE TSI Incorporated
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All